EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Personalized Smartphone Messaging for Secondary Prevention After Percutaneous Coronary Intervention: Randomized Controlled Trial

Sunki Lee, Ji Bak Kim, Seung Eon Shin, Jeonghoon Ahn, Hyun-Ghang Jeong, Kyung Ho Jung, Younghoon Song, Eung Ju Kim

Journal of Medical Internet Research · 2026

DOI: 10.2196/81524 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Medical Internet Research, 2026. Verfasst von Sunki Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Korea University Guro Hospital, 148, Gurodong-Ro, Guro-gu, Seoul, 08308, Republic of Korea, 1 82-2-2626-3022. Hauptthemen laut MEDLINE: Smartphone, Percutaneous Coronary Intervention, Secondary Prevention, Mobile Applications. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cardiac rehabilitation improves outcomes after percutaneous coronary intervention (PCI), but participation remains suboptimal due to barriers such as distance, cost, and lack of referral. Mobile health interventions may enhance accessibility and engagement.

Objective

This study evaluated the effectiveness and user acceptability of a smartphone messaging app (AnSim) in improving cardiovascular risk factors among patients who recently underwent PCI.

Methods

A 2-arm randomized controlled trial was conducted at 2 Korean hospitals; 120 patients who had undergone PCI within the prior month were randomized (1:1) to receive AnSim plus usual care (intervention) or usual care alone (control). The intervention comprised personalized messages tailored by behavioral stage and risk profile, delivered 6 times/week for 6 months. Outcomes were assessed at baseline, 6 months, and 9 months. The primary outcome was change in blood pressure (BP) at 6 and 9 months. Secondary outcomes were lipid profiles, hemoglobin A 1c , BMI, smoking status, physical activity, and achievement of guideline-recommended risk-factor targets. User acceptability was assessed by questionnaire.

Results

Overall, 115 (95.8%; intervention: n=58, control: n=57) participants completed follow-up at 6 months and 110 (91.7%; intervention: n=54, control: n=56) at 9 months. At 6 months, systolic BP was 124.9 (SD 16.7) mmHg in the intervention group and 124.8 (SD 13.1) mmHg in the control group (between-group difference 0.1 mmHg, 95% CI −5.4 to 5.6), and diastolic BP was 80.2 (SD 11.4) mmHg vs 78.4 (SD 10.6) mmHg (difference 1.8 mmHg, 95% CI −2.3 to 5.9). At 9 months, systolic BP was 126 (SD 14.2) mmHg vs 128 (SD 15.4) mmHg (difference −2 mmHg, 95% CI −7.6 to 3.6), and diastolic BP was 80.8 (SD 13.2) mmHg vs 81.3 (SD 12.0) mmHg (difference −0.5 mmHg, 95% CI −5.3 to 4.3). No significant between-group differences were observed in secondary outcomes. In post hoc analyses, participants with above-median message reading were more likely to achieve ≥4 of 5 guideline-recommended risk-factor targets at 9 months (69% vs 19.2%; relative risk 3.59, 95% CI 1.57‐8.18; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SmartphonePercutaneous Coronary InterventionSecondary PreventionMobile ApplicationsText MessagingHumansFemaleMaleMiddle AgedAgedBlood PressureRepublic of Korea

Stichwörter der Autor:innen

cardiac rehabilitationcoronary artery diseasemHealthmobile healthrisk factor modificationsecondary preventionsmartphone apptext messaging

Autor:innen und Institutionen

  • Department of Cardiology, Korea University Guro Hospital, 148, Gurodong-Ro, Guro-gu, Seoul, 08308, Republic of Korea, 1 82-2-2626-3022.
  • Division of Cardiology, Department of Internal Medicine, Hanil General Hospital, Seoul, Republic of Korea.
  • Department of Health Convergence, Ewha Womans University, Seoul, Republic of Korea.
  • Department of Psychiatry, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
  • Department of IT Business, Hanmi Pharmaceutical (South Korea), Seoul, Republic of Korea.

Zitieren

APA

Lee, S., Kim, J. B., Shin, S. E., Ahn, J., Jeong, H. G., Jung, K. H., Song, Y., & Kim, E. J. (2026). Personalized Smartphone Messaging for Secondary Prevention After Percutaneous Coronary Intervention: Randomized Controlled Trial. Journal of Medical Internet Research. https://doi.org/10.2196/81524

Vancouver

Lee S, Kim JB, Shin SE, Ahn J, Jeong HG, Jung KH, et al. Personalized Smartphone Messaging for Secondary Prevention After Percutaneous Coronary Intervention: Randomized Controlled Trial. Journal of Medical Internet Research. 2026. doi:10.2196/81524

BibTeX
@article{Lee2026,
  author = {Lee, Sunki and Kim, Ji Bak and Shin, Seung Eon and Ahn, Jeonghoon and Jeong, Hyun-Ghang and Jung, Kyung Ho and Song, Younghoon and Kim, Eung Ju},
  title = {Personalized Smartphone Messaging for Secondary Prevention After Percutaneous Coronary Intervention: Randomized Controlled Trial},
  journal = {Journal of Medical Internet Research},
  year = {2026},
  doi = {10.2196/81524}
}
Kostenlos starten →